OmniaBio
Pavel Neogi, MBiotech, PMP, LSSGB, is a highly experienced professional with a background in Biotechnology and Project Management. Currently serving as a Program Manager at OmniaBio, Pavel specializes in GMP Compliance Transformation within the Cell and Gene Therapy industry. With previous roles at companies like Sanofi Pasteur and University of Guelph, Pavel has honed their skills in areas such as outsourcing strategies, deviation investigation, and analytical method development. Through their various positions, Pavel has demonstrated strong attention to detail, expertise in scientific instrumentation, and a commitment to maintaining high-quality standards.
This person is not in the org chart
This person is not in any teams
OmniaBio
OmniaBio Inc., a subsidiary of CCRM, launched July 1, 2022. OmniaBio is a contract development and manufacturing organization (CDMO) conducting process development and producing gene-modified cells and viral vectors for Phase I clinical trials to commercial-scale manufacturing. OmniaBio is bringing life-saving cell and gene therapies to patients in Canada and around the world.